XML 25 R13.htm IDEA: XBRL DOCUMENT v3.24.3
Equity Method and Other Investments
 9 Months Ended
Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]  
Equity Method Investments and Joint Ventures Disclosure Equity method and other investments
The Company maintains equity method and other minor investments in the private securities of certain other healthcare and healthcare-related businesses as follows:
September 30, 2024December 31, 2023
Mozarc Medical Holding LLC$238,572 $324,711 
APAC joint venture66,833 98,865 
Other equity method partnerships103,303 107,282 
Adjusted cost method and other investments21,775 14,990 
$430,483 $545,848 
During the nine months ended September 30, 2024 and 2023 the Company recognized equity investment income of $15,874 and $22,502, respectively, from its equity method investments in nonconsolidated dialysis partnerships. The Company also recognized equity investment losses from other equity method investments of $(86,821) and $(38,653) in other loss, net during the nine months ended September 30, 2024 and 2023, respectively.
See Note 8 to the Company's consolidated financial statements included in the 2023 10-K for further description of the Company's equity method investments.